NewAmsterdam Pharma NAMS underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.5, a high ...

Q3 2024 Earnings Call Transcript November 5, 2024 Rhythm Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.73, expectations were $-0.8. Operator: Good day, and thank you for ...

The group’s Chinese medicine segment primarily drove revenue, which contributed $807.8m. Tianjin Pharmaceutical Da Ren Tang ...

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 438,466.47 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical ...

Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.

Enticed by a reward of $1 million, a former police officer helped a foreign scam syndicate use Singapore as a conduit to ...

With greater digital engagement and opportunities available as the world emerges from the COVID-19 pandemic, putting data to use is critical for healthcare and the pharmaceutical industry.

Net profit before taxes saw a 9.8% year-on-year (YoY) increase at $41.1m (AED151m) whilst the group’s revenue climbed 14% YoY in Q3, reaching $353.9m (AED1.3b).

Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 40%. Looking ahead, revenue ...

IPC Indice de Precios Y Cotizaciones 50,831.51-51.03-0.10% ...